| 0 (0%) | 02-21 18:27 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.47 | 1-year : | 33.25 |
| Resists | First : | 24.37 | Second : | 28.47 |
| Pivot price | 24.19  |
|||
| Supports | First : | 24.11 | Second : | 23.95 |
| MAs | MA(5) : | 24.26 |
MA(20) : | 24.18 |
| MA(100) : | 24.01 |
MA(250) : | 23.52 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 72.5 |
D(3) : | 79 |
| RSI | RSI(14): 53.5 |
|||
| 52-week | High : | 24.37 | Low : | 21.96 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IBD ] has closed below upper band by 43.7%. Bollinger Bands are 39.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 24.36 - 24.48 | 24.48 - 24.57 |
| Low: | 23.86 - 24.03 | 24.03 - 24.16 |
| Close: | 23.99 - 24.24 | 24.24 - 24.44 |
Fri, 20 Feb 2026
Embedded Pharmacists Among Keys to Better IBD Care - Specialty Pharmacy Continuum
Fri, 20 Feb 2026
Certain Occupations Linked to Higher IBD Risk - Medscape
Thu, 19 Feb 2026
Can IBD Come Back After Surgery? What You Need to Know - HealthCentral
Thu, 19 Feb 2026
Here's Exactly How High Colorectal Cancer Risk Is for IBD Patients - MedPage Today
Wed, 18 Feb 2026
Grand Rounds February 13, 2026: The Making of the COMPARE-Pediatric IBD Study (Michael D. Kappelman, MD, MPH) - Rethinking Clinical Trials
Tue, 17 Feb 2026
Monster Beverage, Stock Of The Day, Near Buy Point As Growth Accelerates - Investor's Business Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|